Technical Analysis for IOBT - IO Biotech, Inc.
| Grade | Last Price | % Change | Price Change |
|---|---|---|---|
| F | 1.42 | -2.07% | -0.03 |
IOBT closed down 0.68 percent on Thursday, April 25, 2024, on 34 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- so don't be surprised if it goes sideways or bounces.
Earnings due: May 13
*** please verify all earnings dates ***| ADX | Long Term | Intermediate Term | Short Term |
|---|---|---|---|
| Weak or Absent | Down | Down | Down |
| Date | Alert Name | Type | % Chg |
|---|---|---|---|
| Gapped Up | Strength | -2.07% | |
| Oversold Stochastic | Weakness | -2.07% | |
| NR7 | Range Contraction | -2.74% | |
| Inside Day | Range Contraction | -2.74% | |
| Oversold Stochastic | Weakness | -2.74% | |
| Inside Day | Range Contraction | -3.40% | |
| Oversold Stochastic | Weakness | -3.40% | |
| Lower Bollinger Band Walk | Weakness | -1.39% | |
| Oversold Stochastic | Weakness | -1.39% | |
| 200 DMA Resistance | Bearish | -4.05% |
| Alert | Time |
|---|---|
| Rose Above 10 DMA | about 4 hours ago |
| Rose Above Previous Day's High | about 4 hours ago |
| 10 DMA Resistance | about 4 hours ago |
| Up 5% | about 4 hours ago |
| Up 3% | about 4 hours ago |
Get this analysis on your stocks daily!
Let us help you stay on top of your investments. We will alert you to important technical developments on your
portfolio & watchlist.
Configure default chart indicators
Basic chart:
- Earnings date: 05/13/2024
IO Biotech, Inc., a clinical-stage biopharmaceutical company, develops disruptive immune modulating anti-cancer therapies in Denmark. The company's lead product candidate, IO102-IO103, is designed to target immunosuppressive proteins, such as Indoleamine 2,3-dehydrogenase (IDO), and programmed death ligand (PD-L1). It also develops IO112, a product candidate that contains a single Arginase 1-derived peptide designed to target T cells that recognize epitopes derived from Arginase 1 for the treatment of cancers. IO Biotech, Inc. was incorporated in 2021 and is based in Copenhagen, Denmark.
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immune System Treatment Of Cancer Cancer Therapies Anti Cancer Therapies Urea Cycle
Classification
Sector: Healthcare
Industry: Biotechnology
Keywords: Biopharmaceutical Cancer Immune System Treatment Of Cancer Cancer Therapies Anti Cancer Therapies Urea Cycle
| Indicator | Bull Case | Neutral / Hold | Bear Case |
|---|---|---|---|
| 50 DMA | |||
| 200 DMA | |||
| ADX Trend | |||
| Oversold / Overbought | |||
| Relative Strength |
| Indicator | Value |
|---|---|
| 52 Week High | 2.64 |
| 52 Week Low | 0.8163 |
| Average Volume | 137,993 |
| 200-Day Moving Average | 1.55 |
| 50-Day Moving Average | 1.61 |
| 20-Day Moving Average | 1.56 |
| 10-Day Moving Average | 1.48 |
| Average True Range | 0.11 |
| RSI (14) | 36.71 |
| ADX | 24.46 |
| +DI | 5.80 |
| -DI | 13.06 |
| Chandelier Exit (Long, 3 ATRs) | 1.46 |
| Chandelier Exit (Short, 3 ATRs) | 1.75 |
| Upper Bollinger Bands | 1.75 |
| Lower Bollinger Band | 1.38 |
| Percent B (%b) | 0.2 |
| BandWidth | 23.82 |
| MACD Line | -0.06 |
| MACD Signal Line | -0.05 |
| MACD Histogram | -0.01 |
| Pivot Point Level | Traditional / Classic | Fibonacci | Demark | Woodie | Camarilla |
|---|---|---|---|---|---|
| Resistance 4 (R4) | 1.57 | ||||
| Resistance 3 (R3) | 1.57 | 1.54 | 1.55 | ||
| Resistance 2 (R2) | 1.54 | 1.51 | 1.54 | 1.54 | |
| Resistance 1 (R1) | 1.49 | 1.49 | 1.48 | 1.49 | 1.54 |
| Pivot Point | 1.46 | 1.46 | 1.45 | 1.46 | 1.46 |
| Support 1 (S1) | 1.41 | 1.43 | 1.40 | 1.41 | 1.36 |
| Support 2 (S2) | 1.38 | 1.41 | 1.38 | 1.36 | |
| Support 3 (S3) | 1.33 | 1.38 | 1.35 | ||
| Support 4 (S4) | 1.33 |
